{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:42:00Z","timestamp":1760784120556},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clin Oncol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1111\/ajco.12489","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T05:26:49Z","timestamp":1459402009000},"page":"254-258","source":"Crossref","is-referenced-by-count":1,"title":["A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin"],"prefix":"10.1111","volume":"12","author":[{"given":"Akimitsu","family":"Maeda","sequence":"first","affiliation":[{"name":"Department of Pharmacy; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ura","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisa","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikue","family":"Haegawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoo","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiya","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenori","family":"Kadowaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Muro","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Horio","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Oze","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Prevention; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kajita","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Aichi Cancer Center Research Institute; Chikusa-ku Nagoya Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"10.1111\/ajco.12489-BIB0001|ajco12489-cit-0001","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","article-title":"Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment","volume":"24","author":"Bloechl-Daum","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"10.1111\/ajco.12489-BIB0002|ajco12489-cit-0002","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","article-title":"Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conference","volume":"21","author":"Roila","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1111\/ajco.12489-BIB0003|ajco12489-cit-0003","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajco.12489-BIB0004|ajco12489-cit-0004","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1517\/17425250903451675","article-title":"Prevention of chemotherapy induced nausea and vomiting: A focus on aprepitant","volume":"5","author":"Sankhala","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/ajco.12489-BIB0005|ajco12489-cit-0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2009.10.002","article-title":"Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function","volume":"626","author":"Rojas","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/ajco.12489-BIB0006|ajco12489-cit-0006","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","article-title":"Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: A double-blind, double-dummy, randomised, comparative phase III trial","volume":"10","author":"Saito","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1111\/ajco.12489-BIB0007|ajco12489-cit-0007","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00520-014-2175-6","article-title":"Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): A systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Popovic","year":"2014","journal-title":"Supportive Care Cancer"},{"key":"10.1111\/ajco.12489-BIB0008|ajco12489-cit-0008","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","article-title":"Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan","volume":"20","author":"Tamura","year":"2015","journal-title":"Intl J Clin Oncol"},{"issue":"Suppl","key":"10.1111\/ajco.12489-BIB0009|ajco12489-cit-0009","article-title":"Palonosetron (PALO) versus granisetron (GRA) in the triplet regimen with dexamethasone (DEX) and aprepitant (APR) for preventing chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving highly emeto-genic chemotherapy (HEC) with cisplatin (CDDP): A randomized, double-blind, phase III trial.)","author":"Suzuki","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajco.12489-BIB0010|ajco12489-cit-0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/ajco.12489-BIB0011|ajco12489-cit-0011","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-2999(01)01399-1","article-title":"Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine","volume":"430","author":"Bymaster","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/ajco.12489-BIB0012|ajco12489-cit-0012","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.suponc.2011.05.002","article-title":"Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A randomized phase III trial","volume":"9","author":"Navari","year":"2011","journal-title":"J Supportive Oncol"},{"key":"10.1111\/ajco.12489-BIB0013|ajco12489-cit-0013","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jpainsymman.2013.05.003","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy: A randomized, double-blind, placebo-controlled study","volume":"47","author":"Mizukami","year":"2014","journal-title":"J Pain Symp Manage"},{"key":"10.1111\/ajco.12489-BIB0014|ajco12489-cit-0014","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1756-9966-28-131","article-title":"Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting","volume":"28","author":"Tan","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1111\/ajco.12489-BIB0015|ajco12489-cit-0015","volume-title":"Statistical Methods for Rates and Proportions","author":"Joseph","year":"2003"},{"key":"10.1111\/ajco.12489-BIB0016|ajco12489-cit-0016","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"10.1111\/ajco.12489-BIB0017|ajco12489-cit-0017","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1038\/srep04813","article-title":"A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"10.1111\/ajco.12489-BIB0018|ajco12489-cit-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000000762","article-title":"Neurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: A systematic review and meta-analysis","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajco.12489","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajco.12489\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T08:24:37Z","timestamp":1625300677000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajco.12489"}},"subtitle":["Olanzapine for cisplatin-induced vomiting"],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1111\/ajco.12489","archive":["Portico"],"relation":{},"ISSN":["1743-7555"],"issn-type":[{"value":"1743-7555","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}